ALGAE
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw mat… Read more
ALGAE (ALGAE) - Total Assets
Latest total assets as of June 2025: €46.99 Million EUR
Based on the latest financial reports, ALGAE (ALGAE) holds total assets worth €46.99 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ALGAE - Total Assets Trend (2011–2024)
This chart illustrates how ALGAE’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ALGAE - Asset Composition Analysis
Current Asset Composition (December 2024)
ALGAE's total assets of €46.99 Million consist of 52.2% current assets and 47.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €18.97 Million | 40.2% |
| Accounts Receivable | €2.94 Million | 5.8% |
| Inventory | €1.06 Million | 2.1% |
| Property, Plant & Equipment | €9.54 Million | 18.7% |
| Intangible Assets | €14.86 Million | 29.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2011–2024)
This chart illustrates how ALGAE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ALGAE's current assets represent 52.2% of total assets in 2024, a decrease from 54.5% in 2011.
- Cash Position: Cash and equivalents constituted 40.2% of total assets in 2024, down from 43.7% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is cash and equivalents at 40.2% of total assets.
ALGAE Competitors by Total Assets
Key competitors of ALGAE based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
ALGAE - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - ALGAE generates 0.22x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - ALGAE is currently not profitable relative to its asset base.
ALGAE - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.88 | 3.67 | 2.02 |
| Quick Ratio | 1.83 | 3.42 | 1.82 |
| Cash Ratio | 0.98 | 2.41 | 0.00 |
| Working Capital | €10.70 Million | € 20.73 Million | € 10.23 Million |
ALGAE - Advanced Valuation Insights
This section examines the relationship between ALGAE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.41 |
| Latest Market Cap to Assets Ratio | 0.58 |
| Asset Growth Rate (YoY) | 1.8% |
| Total Assets | €51.14 Million |
| Market Capitalization | $29.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values ALGAE's assets below their book value (0.58 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: ALGAE's assets grew by 1.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for ALGAE (2011–2024)
The table below shows the annual total assets of ALGAE from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €51.14 Million | +1.79% |
| 2023-12-31 | €50.24 Million | -12.68% |
| 2022-12-31 | €57.54 Million | -5.48% |
| 2021-12-31 | €60.88 Million | +45.34% |
| 2020-12-31 | €41.89 Million | +21.28% |
| 2019-12-31 | €34.54 Million | -26.09% |
| 2018-12-31 | €46.73 Million | -13.48% |
| 2017-12-31 | €54.01 Million | +17.16% |
| 2016-12-31 | €46.09 Million | -13.61% |
| 2015-12-31 | €53.35 Million | -0.06% |
| 2014-12-31 | €53.39 Million | +200.46% |
| 2013-12-31 | €17.77 Million | +135.84% |
| 2012-12-31 | €7.53 Million | +5.16% |
| 2011-12-31 | €7.16 Million | -- |